Paolo Tarantino: Can emotional distress impact treatment outcomes with IO?
Paolo Tarantino, Clinical Research Fellow at the Dana-Farber Cancer Institute, shared a recent article by him and Federica Pecci on X:
“Can emotional distress impact treatment outcomes with IO?
The prospective stress lung study suggests so, with reduced PFS and ORR among patients with baseline depression or anxiety.
In this editorial on TLCR, Federica Pecci and I put the results into context.”
Authors: Federica Pecci and Paolo Tarantino
Dr. Paolo Tarantino, MD, is pursuing an advanced research fellowship at Dana-Farber Cancer Institute and Harvard Medical School, concurrently working towards a PhD in clinical research at the University of Milan.
His research focuses on exploring the HER2 oncoprotein, investigating the emerging HER2-low subgroup of breast tumors, and developing novel antibody-drug conjugates targeting every subtype of breast cancer.
More posts featuring Paolo Tarantino.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023